A purple and pink letter v on a white background.
July 7, 2020

Filters and Fillers: Social Media Dysmorphia In Medical Aesthetics

Patients seek consultations for various reasons. However, there is a new common factor that influences people’s decision to get a cosmetic treatment: social media. A person with social media dysmorphia (SMD), or selfie or Snapchat dysmorphia, may have a body dysmorphic disorder (BDD) that can be triggered or worsened by social media.

Social Media’s Impact on Perception of Appearance

Many social media users are accustomed to sharing selfies that have been altered with filters to erase imperfections. Constant exposure to this enhanced version of oneself—combined with the positive feedback in the form of likes, shares, and follows—can make people feel their unedited selves aren’t enough. Some potential patients may even present a modified selfie to demonstrate aesthetic goals, regardless of whether or not they are realistic.

While social media dysmorphia isn’t a recognized diagnosis per the DSM-5, the term still reflects the way that social media can impact someone with BDD. A person with BDD is usually obsessed with self-perceived flaws that others likely do not notice. Too often, this psychological disorder is mis- or undiagnosed.

While social media doesn’t cause BDD, it can trigger or worsen it. Teenagers and influencers are often at higher risk for developing BDD because of their excessive use. Influencers may perceive their market value to directly correlate to the number and quality of their social media interactions.

The Importance of Assessing Patients for BDD

There is a clear connection between social media use and demand for cosmetic enhancements. In fact, more than half of aesthetic surgeons say they’ve seen an increase in the number of patients who want treatments specifically to improve their selfies. However, it’s important to screen prospective patients for SMD and BDD for a number of reasons:

Researchers estimate that up to 15% of patients seeking cosmetic enhancement procedures have BDD, the majority of whom are women. Because SMD is a relatively new development, however, it isn’t clear yet how many people have it.

Screening for BDD

Symptoms of BDD include:

  • Camouflaging : A patient may attempt to hide perceived flaws with makeup or clothing. He or she might also repeatedly consult a mirror.
  • Comparing : You may notice someone persistently comparing him or herself to others.
  • Seeking reassurance : A person with BDD might frequently seek other’s opinions or reassurance from social media.
  • Behaviors to change external appearance : This could include tanning, excessive exercising, or changing clothes in an attempt to have more control over a perceived flaw.
  • Excessive cosmetic treatments : A patient might opt for multiple procedures, but express little satisfaction with the results.
  • Social anxiety and avoidance : Though not exclusive to BDD, worrying about being rejected in social situations is a common sign, as is recurrent conflicts with friends, family, and/or coworkers.

While it can be difficult to determine whether a patient’s perception of his or her flaws is warranted, medical aesthetic experts should screen clients for possible mental health concerns prior to administering treatment. One survey found that 84% of aesthetic practitioners had treated a person they considered an appropriate candidate and later determined that the recipient had BDD .

To better identify patients who may have BDD and/or social media dysmorphia, pay attention to their concerns. If someone presents edited selfies during a consultation, ask how much the pictures been edited. Be clear and firm about what aesthetic treatment can and can’t do. You can also ask a candidate to identify flaws in a mirror. This could help you get a better sense of his or her self-perception.

Another way to screen for BDD is to use a questionnaire that lists common symptoms. Have patients rate the severity of distress for each one. If a person has symptoms of BDD, you can then refer them to a mental health specialist.

Before treating any patient, you should address these questions:

  1. Are his or her aesthetic goals realistic and attainable?
  2. Is the treatment safe for this person?
  3. Is the patient seeking treatment for the right reasons?

The Importance of Offering a Wide Range of Aesthetic Treatments 

With social media playing an ever-increasing role in people’s lives , it is imperative to keep BDD and SMD in mind during each consultation. To avoid dramatic surgical outcomes that may not be reversible, consider providing non-invasive solutions to better serve your patients.

Venus Concept offers an extensive lineup of cutting-edge, non-invasive medical aesthetic devices and post-sales support services. Contact us today for more information or download our report, “ Filters and Fillers: The Growing Incidence of Social Media Dysmorphia in the Medical Aesthetics Space.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.